Iterum Therapeutics(ITRM) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Iterum Therapeutics plc (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorporation or organization) Ireland 98-1283148 (I.R.S. Employer Identification No.) Fitzwilliam Court, 1st Floor, Leeson Close, Dublin 2, Ireland (Address of principal execut ...